Requirement of TGF-β Receptor-Dependent Activation of c-Jun N-Terminal Kinases (JNKs)/Stress-Activated Protein Kinases (Sapks) for TGF-β Up-Regulation of the Urokinase-Type Plasminogen Activator Receptor

Journal of Cellular Physiology

Volumn 199, Issue 2, 2004, Pages 284-292

  Yue, Jianbo ^a,b   Sun, Baodong ^a   Liu, Guangming ^a   Mulder, Kathleen M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUND; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TIME; UPREGULATION;

ANIMALS; CELLS, CULTURED; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; IMMUNOBLOTTING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 1842421169     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10469     Document Type: Article

References (60)

1. Atfi A, Djelloul S, Chastre E, Davis R, Gespach C. 1997. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (Sapk) in transforming growth factor β-mediated signaling. J Biol Chem 272:1429-1432.
2. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
3. Bottinger EP, Jakubczak JL, Roberts IS, Mumy M, Hemmati P, Bagnall K, Merlino G, Wakefield LM. 1997. Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential roles for TGF-β in regulation of growth and differentiation in the exocrine pancreas. EMBO J 16:2621-2633.
4. Brunner N, Nielsen HJ, Hamers M, Christensen IJ, Thorlacius-Ussing O, Stephens RW. 1999. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. APMIS 107:160-167.
5. Chung KY, Agarwal A, Uitto J, Mauviel A. 1996. An AP-1 binding sequence is essential for regulation of the human a2 (I) collagen (COL1A2) activity by transforming growth factor β. J Biol Chem 271:3272-3278.
6. Dang J, Boyd D, Wang H, Allgayer H, Doe WF, Wang Y. 1999. A region between -141 and -61 bp containing a proximal Ap-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor. Eur J Biochem 264:92-99.
7. Eickelberg O, Pansky A, Mussmann R, Bihl M, Tamm M, Hildebrand P, Perruchoud AP, Roth M. 1999. Transforming growth factor β1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem 274:12933-12938.
8. Engel ME, McDonnell MA, Law BK, Moses HL. 1999. Interdependent Smad and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 274:37413-37420.
9. Falcone DJ, McCaffrey TA, Mathew J, McAdam K, Borth W. 1995. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta via increased expression of urokinase and urokinase receptor. J Cell Physiol 164:334-343.
10. Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, Gulino A, Mackay AR. 1998. Transforming growth factor-β1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer 75:721-730.
11. Ferrell JE, Jr. 1996. Tripping the switch fantastic: How a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem Sci 21:460-466.
12. Frey RS, Mulder KM. 1997. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res 57:628-633.
13. Gum R, Juarez J, Allgayer H, Mazar A, Wang Y, Boyd D. 1998. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene 17:213-225.
14. mapk in proliferating cultures of epithelial cells. J Biol Chem 270:7117-7124.
15. Hartsough MT, Mulder KM. 1997. Transforming growth factor-β signaling in epithelial cells. Pharmacol Ther 75:21-41.
16. Hartsough MT, Frey R, Zipfel P, Buard A, Cook S, McCormick F, Mulder KM. 1996. Altered transforming growth factor β signaling in epithelial cells when Ras activation is blocked. J Biol Chem 271:22368-22375.
17. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
18. Hocevar BA, Brown TL, Howe PH. 1999. TGFβ induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-1356.
19. Huang CY, Ferrell JE, Jr. 1996. Ultrasensitivity in the mitogen-activated protein kinase cascade. PNAS USA 93:10078-10083.
20. Johnsen M, Lund LR, Romer J, Almholt K, Dano K. 1998. Cancer invasion and tissue remodeling: Common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10:667-671.
21. Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorletto PE, Moses HL. 1986. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: A proposed model for indirect mitogenesis involving autocrine activity. PNAS USA 83:2453-2457.
22. Lund LR, Romer J, Ronne E, Ellis V, Blasi F, Dano K. 1991. Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J 10:3399-3407.
23. Majack RA, Majesky MW, Goodman LV. 1990. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol 111:239-247.
24. Massague J. 1996. TGFβ signaling: Receptors, transducers and Mad proteins. Cell 85:947-950.
25. Massague J, Blain SW, Lo RS. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
26. Mauviel A, Chung KY, Agarwal A, Tamai K, Uitto J. 1996. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor β in fibroblasts and keratinocytes. J Biol Chem 271:10917-10923.
27. Mulder KM. 1991. Differential regulation of c-myc and transforming growth factor-a messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during establishment of a quiescent state. Cancer Res 51:2256-2262.
28. Mulder KM. 2000. Role of Ras and MAPKs in TGFβ signaling. Cytokine Growth Factor Rev 11:23-35.
29. ras by transforming growth factor β in epithelial cells. J Biol Chem 267:5029-5031.
30. Mulder KM, Segarini PR, Morris SL, Ziman JM, Choi HG. 1993. Role of receptor complexes in resistance or sensitivity to growth inhibition by TGFβ in intestinal epithelial cell clones. J Cell Physiol 154:162-174.
31. Murakami M, Sonobe MH, Ui Y, Kabuyama Y, Watanabe H, Wada T, Handa H, Iba H. 1997. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: A pathway of activation of endogenous AP-1. Oncogene 14:2435-2444.
32. Murakami M, Ui M, Iba H. 1999. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. Cell Growth Differ 10:333-342.
33. Park IK, Lyu MA, Yeo SJ, Han TH, Kook YH. 2000. Sp1 mediates constitutive and transforming growth factor beta-inducible expression of urokinase type plasminogen activator receptor gene in human monocyte-like U937 cells. Biochim Biophys Acta 1490:302-310.
34. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. 2001. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3:708-714.
35. Rabbani SA, Xing RH. 1998. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int J Oncol 12:911-920.
36. Reuning U, Magdolen V, Wilhelm O, Fischer K, Lutz V, Graeff H, Schmitt M. 1998. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int J Oncol 13:893-906.
37. Santibanez JF, Iglesias M, Frontelo P, Martinez J, Quintanilla M. 2000. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes. Biochem Biophys Res Commun 273:521-527.
38. Seifert RA, Coats SA, Raines EW, Ross R, Bowen-Pope DF. 1994. Platelet-derived growth factor (PDGF) receptor a-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-β can be mitogenic through PDGF A-chain-dependent and -independent pathways. J Biol Chem 269:13951-13955.
39. Shetty S, Kumar A, Johnson A, Pueblitz S, Idell S. 1995. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogensis and proteolysis. Am J Physiol 268:L972-L982.
40. Sidenius N, Blasi F. 2003. The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer Metastat Rev 22:205-222.
41. Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Dano K, Brunner N, Blasi F. 1998. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 58:1843-1849.
42. Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sorensen S, Dano K, Brunner N. 1999. Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis. J Natl Cancer Inst 91:869-874.
43. Suzuki T, Okuno H, Yoshida T, Endo T, Nishina H, Iba H. 1991. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res 19:5537-5542.
44. Tang Q, Staub CM, Gao G, Jin Q, Wang Z, Ding W, Aurigemma RE, Mulder KM. 2002. A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein. Mol Biol Cell 13:4484-4496.
45. Uria JA, Jimenez MG, Balbin M, Freije JMP, Lopez-Otin C. 1998. Differential effects of transforming growth factor β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 272:9769-9777.
46. Virolle T, Monthouel MN, Djabari Z, Ortonne JP, Meneguzzi G, Aberdam D. 1998. Three activator protein-1-binding sites bound by the Fra-2-JunD complex cooperate for the regulation of murine laminin alpha3A (Lama3A) promoter activity by transforming growth factor β. J Biol Chem 273:17318-17325.
47. Wang Y. 2001. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med Res Rev 21:146-170.
48. Westermarck J, Kahari VM. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792.
49. Whitmarsh AJ, Davis RJ. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607.
50. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGFβ signaling transduction. Science 270:2008-2011.
51. Young MR, Nair R, Bucheimer N, Tulsian P, Brown N, Chapp C, Hsu TC, Colburn NH. 2002. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol Cell Biol 22:587-598.
52. 1 production in a Smad-dependent pathway. J Biol Chem 275:30765-30776.
53. Yue J, Mulder KM. 2000b. Transforming growth factor-β protocols: Activation of the mitogen-activated protein kinase pathway by transforming growth factor-β. In: Howe PH, editor. Methods in molecular biology. Totowa, NJ: Humana Press, Inc. pp 125-131.
54. Yue J, Mulder KM. 2001. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 91:1-34.
55. Cip1 by expression of RasN17 in epithelial cells. Oncogene 17:47-55.
56. Yue J, Frey RS, Mulder KM. 1999a. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβ. Oncogene 18:2033-2037.
57. Yue J, Hartsough MT, Frey RS, Frielle T, Mulder KM. 1999b. Cloning and expression of a rat Smad1: Regulation by TGFβ and modulation by the Ras/ MEK pathway. J Cell Physiol 178:387-396.
58. Zhang Y, Feng XH, Derynck R. 1998. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGFβ-induced transcription. Nature 394:909-913.
59. Zhou G, Lee SL, Yao Z, Tan TH. 1999. Hematopoietic progenitor kinase 1 is a component of transforming growth factor β-induced c-Jun N-terminal kinase signaling cascade. J Biol Chem 274:13133-13138.
60. Zipfel PA, Ziober BL, Morris SM, Mulder KM. 1993. Up-regulation of transforming growth factor a expression by transforming growth factor β1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cell. Cell Growth Differ 4:637-645.